M. Mohty, Mechanisms of action of antithymocyte globulin: T-cell depletion and beyond, Leukemia, vol.21, pp.1387-1394, 2007.

D. Cantarovich, L. Rostaing, and N. Kamar, FRANCIA Study Trial Investigators Group. Early corticosteroid avoidance in kidney transplant recipients receiving ATG-F induction: 5-year actual results of a prospective and randomized study, Am J Transplant, vol.14, pp.2556-2564, 2014.

R. A. Dwek, A. C. Lellouch, and M. R. Wormald, Glycobiology: 'the function of sugar in the IgG molecule, J Anat, vol.187, issue.2, pp.279-292, 1995.

M. R. Wormald, P. M. Rudd, and D. J. Harvey, Variations in Oligosaccharide ? Protein Interactions in Immunoglobulin G Determine the SiteSpecific Glycosylation Profiles and Modulate the Dynamic Motion of the Fc Oligosaccharides, Biochemistry (Mosc), vol.36, pp.1370-1380, 1997.

S. E. Gitelman, P. A. Gottlieb, and M. R. Rigby, START Study Team. Antithymocyte globulin treatment for patients with recent-onset type 1 diabetes: 12-month results of a randomised, placebo-controlled, phase 2 trial, Lancet Diabetes Endocrinol, vol.1, pp.306-316, 2013.

J. P. Soulillou, D. Cantarovich, L. Mauff, and B. , Randomized controlled trial of a monoclonal antibody against the interleukin-2 receptor (33B3.1) as compared with rabbit antithymocyte globulin for prophylaxis against rejection of renal allografts, N Engl J Med, vol.322, pp.1175-1182, 1990.

S. A. Wolanin, J. G. Demain, and E. A. Meier, Successful desensitization of a patient with aplastic anemia to antithymocyte globulin, Allergy Rhinol (Providence), vol.6, pp.64-67, 2015.

G. Couvrat-desvergnes, A. Salama, L. Berre, and L. , Rabbit antithymocyte globulin-induced serum sickness disease and human kidney graft survival, J Clin Invest, vol.125, pp.4655-4665, 2015.
DOI : 10.1172/jci82267

URL : https://hal.archives-ouvertes.fr/inserm-02147235

J. D. Berry and R. G. Gaudet, Antibodies in infectious diseases: polyclonals, monoclonals and niche biotechnology, N Biotechnol, vol.28, pp.489-501, 2011.

C. H. Chung, B. Mirakhur, and E. Chan, Cetuximab-induced anaphylaxis and IgE specific for galactose-alpha-1,3-galactose, N Engl J Med, vol.358, pp.1109-1117, 2008.
DOI : 10.1056/nejmoa074943

URL : http://europepmc.org/articles/pmc2361129?pdf=render

B. Pirofsky, J. C. Ramirez-mateos, and A. August, Foreign serum" heterophile antibodies in patients receiving antithymocyte antisera, Blood, vol.42, pp.385-393, 1973.

M. Hanganutziu, Hémagglutinines hétérogénétiques après injection de sérum de cheval, CR Séances Soc Biol, vol.91, pp.1457-1459, 1924.

H. Higashi, M. Naiki, and S. Matuo, Antigen of "serum sickness" type of heterophile antibodies in human sera: indentification as gangliosides with N-glycolylneuraminic acid, Biochem Biophys Res Commun, vol.79, pp.388-395, 1977.

J. M. Merrick, K. Zadarlik, and F. Milgrom, Characterization of the Hanganutziu-Deicher (serum-sickness) antigen as gangliosides containing N-glycolylneuraminic acid, Int Arch Allergy Appl Immunol, vol.57, pp.477-480, 1978.

D. K. Cooper, E. Koren, and R. Oriol, Oligosaccharides and discordant xenotransplantation, Immunol Rev, vol.141, pp.31-58, 1994.
DOI : 10.1111/j.1600-065x.1994.tb00871.x

H. H. Chou, H. Takematsu, and S. Diaz, A mutation in human CMP-sialic acid hydroxylase occurred after the Homo-Pan divergence, Proc Natl Acad Sci, vol.95, pp.11751-11756, 1998.

A. Salama, G. Evanno, and J. Harb, Potential deleterious role of antiNeu5Gc antibodies in xenotransplantation, Xenotransplantation, vol.22, pp.85-94, 2015.
URL : https://hal.archives-ouvertes.fr/inserm-02147779

L. Scobie, V. Padler-karavani, L. Bas-bernardet, and S. , Long-term IgG response to porcine Neu5Gc antigens without transmission of PERV in burn patients treated with porcine skin xenografts, J Immunol, vol.191, pp.2907-2915, 2013.

P. Tangvoranuntakul, P. Gagneux, and S. Diaz, Human uptake and incorporation of an immunogenic nonhuman dietary sialic acid, Proc Natl Acad Sci U S A, vol.100, pp.12045-12050, 2003.

M. Bardor, D. H. Nguyen, and S. Diaz, Mechanism of uptake and incorporation of the non-human sialic acid n-glycolylneuraminic acid into human cells, J Biol Chem, vol.280, pp.4228-4237, 2005.

W. G. Couser and D. J. Salant, In situ immune complex formation and glomerular injury, Kidney Int, vol.17, pp.1-13, 1980.

T. Pham, C. J. Gregg, and F. Karp, Evidence for a novel human-specific xenoauto-antibody response against vascular endothelium, Blood, vol.114, pp.5225-5235, 2009.

P. Mathieu, C. Renoult, E. , K. De-march, and A. , Serum anti-rabbit and anti-horse IgG, IgA, and IgM in kidney transplant recipients, Nephrol Dial Transplant, vol.12, pp.2133-2139, 1997.

V. Padler-karavani, A. H. Tremoulet, and H. Yu, A simple method for assessment of human anti-Neu5Gc antibodies applied to Kawasaki disease, PLoS One, vol.8, p.58443, 2013.

R. Buonomano, C. Tinguely, and R. Rieben, Quantitation and characterization of anti-Galalpha1-3Gal antibodies in sera of 200 healthy persons. Xenotransplantation, vol.6, pp.173-180, 1999.

S. E. Gitelman, P. A. Gottlieb, and E. I. Felner, ITN START Study Team. Antithymocyte globulin therapy for patients with recent-onset type 1 diabetes: 2 year results of a randomised trial, Diabetologia, vol.59, pp.1153-1161, 2016.

K. Z. Konakci, B. Bohle, and R. Blumer, Alpha-Gal on bioprostheses: xenograft immune response in cardiac surgery, Eur J Clin Invest, vol.35, pp.17-23, 2005.

F. Naso, A. Gandaglia, and T. Bottio, First quantification of alpha-Gal epitope in current glutaraldehyde-fixed heart valve bioprostheses. Xenotransplantation, vol.20, pp.252-261, 2013.

R. E. Taylor, C. J. Gregg, and V. Padler-karavani, Novel mechanism for the generation of human xeno-autoantibodies against the nonhuman sialic acid N-glycolylneuraminic acid, J Exp Med, vol.207, pp.1637-1646, 2010.